Back

The prevalence of anxiety among patients with implantable cardioverter-defibrillator, does it change with decades of implementations?

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Device Therapy Implantable Cardioverter-Defibrillator (ICD) HFA Premium Access Heart Failure 2019

About the speaker

Photo
Associate Professor Robert Olszewski

National Institute of Geriatrics Rheumatology and Rehabilitation, Warsaw (Poland)

10 More presentations in this session

Presentation thumbnail
Low heart rate at follow up predicts improvement of ejection fraction in a large-volume cohort of women with wearable cardioverter defibrillator
Doctor L. Schrutka (Vienna, AT)
Abstract Slides
Presentation thumbnail
Epicardial adipose tissue echocardiographic thickness predicts arrhythmic outcome in heart failure patients.
Doctor L. Ferrante (Vicenza, IT)
Abstract
Presentation thumbnail
Single lead implantable cardioverter-defibrillator lead system with a atrial sensing dipole (Dx-AICD technology): 1-year follow-up
Doctor P. Sangoi (Chennai, IN)
Abstract Slides
Presentation thumbnail
Appropriate and inappropriate ICD therapy in patients with ischemic and non-ischemic cardiomyopathies according remote monitoring data.
Mr D. Losik (Dubai, AE)
Presentation thumbnail
Frequency and patterns of implantable cardiac defibrillator therapies in patients with left ventricular assist devices
Doctor A. Gkouziouta (Athens, GR)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Device Therapy

The Event

Event poster

Heart Failure 2019

25 May - 28 May 2019
You may be interested in
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Session
Debate on primary prevention in ICD therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources